Interestingly, as SERPINA3 functions as a plasma protease, it may also serve as a potential biomarker for blood-based detection of PCa, enabling precise monitoring of tumor progression and postoperative recurrence in patients with PCa. This evidence concerns the gene SERPINA3 and posterior cortical atrophy.